Advertisement

Johnson & Johnson CEO News

alt
The vaccine jab generated strong, persistent activity against the Delta variant and other highly prevalent SARS-CoV-2 viral variants. Johnson & Johnson's vaccine demonstrated protection against hospitalisation and death.






Loading...
english news
NEWS ON ONE CLICK